Physician profile

Joseph Ott

Pediatrics · Ashland, OH

NPI 1477725729

$191.86

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$116.29

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Cranial Technologies, INC $43.35 2021-2024 Doc Band
Ironshore Pharmaceuticals INC. $34.32 2019-2024
Sanofi Pasteur INC. $27.27 2019
Acadia Pharmaceuticals INC $22.91 2023 Daybue
Merck Sharp & Dohme LLC $20.60 2024 Vaxneuvance, Vaqta, Vaxelis
Takeda Pharmaceuticals U.S.A., INC. $16.00 2021
Pfizer INC. $14.48 2024
Astrazeneca Pharmaceuticals LP $12.93 2023 Flumist Quadrivalent

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Joseph Ott

$191.86

in general payments reported 2019-2025

Years
2019-2024
Top company
Cranial Technologies, INC

https://glasscript.com/doctor/1202286/joseph-ott

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.